Live from Industry: Nasal Decolonization to Prevent Staphylococcus aureus Infections
By registering to this webinar you are agreeing to be contacted by APIC industry partner: PDI
Marin Schweizer, PhD has performed many research studies to evaluate whether nasal decolonization prevents Staphylococcus aureus infections. She will describe her multicenter research studies that evaluated nasal decolonization interventions, including real-world barriers and facilitators to implementation of these interventions. She will also discuss the evidence base for nasal decolonization to prevent S. aureus infections among different patient populations.
- Describe CDC recommended strategies to prevent hospital-onset Staphylococcus aureus infections in acute care facilities
- Discuss barriers and facilitators to nasal decolonization among surgical patients
- Describe patient populations that may benefit from nasal decolonization
- List advantages and disadvantages of different decolonizing agents
Brought to you by PDI.
Disclaimer: The Information presented on APIC Online® does not necessarily reflect the views of APIC and in no event shall APIC assume or have any responsibility or liability for any information posted to APIC Online® or for any claims, damages or losses resulting from the use and/or appearance of such information on APIC Online®.